Meta Restructures Reality Labs: Focus on Metaverse and XR by Lilu Anderson 21.06.2024 Meta restructures Reality Labs into Metaverse and Wearables divisions to streamline AR and VR development and enhance immersive digital experiences.
Top iGaming Tech Innovations in 2024: VR, AI, and Cloud Gaming by Lilu Anderson 21.06.2024 Discover how iGaming in 2024 transforms with AI, Blockchain, VR, and Cloud Gaming, offering immersive experiences and enhanced security.
Analysts: Bitcoin, Ethereum, XRP, and More Show Upside Potential by John Darbie 20.06.2024 Analysts see Bitcoin, Ethereum, XRP, Dogecoin, Toncoin, and Cardano undervalued per MVRV metric; market up 0.6%, possible short-term price bounce.
Before Buying a Quest 2 on Prime Day: Consider These Factors by Lilu Anderson 20.06.2024 "Thinking about a Meta Quest 2 VR headset? Weigh cost vs. future game compatibility and features before purchase. Explore our ...
Cardano, Dogecoin, XRP: Poised for Major Price Surges by John Darbie 20.06.2024 "Cardano, Dogecoin, and XRP show bullish signs with potential for explosive gains. Market indicators suggest short-term bounces."
VR, AR Headset Sales Decline: Market Transition in Focus by Lilu Anderson 20.06.2024 "Global VR, AR headset sales plunge 67.4% in Q1 2024 due to market in transition. Mixed reality gains traction; future ...
Metaverse in Gaming: Market Size, Share & Industry Analysis by Lilu Anderson 19.06.2024 "Explore how the Metaverse in Gaming Market is evolving with VR/AR technologies, major players, and forecasted growth to $323.54B by ...
Virtual Reality Headsets Market: Trends, Drivers & Forecast 2032 by Lilu Anderson 19.06.2024 Explore the Virtual Reality Headsets Market trends, drivers, restraints, and forecast till 2032, including key players and strategic insights.
AR/VR Headset Shipments Plunge 67%, ASP Surges: IDC Report by Lilu Anderson 19.06.2024 Global AR and VR headset shipments dropped 67.4% in Q1 2024, while MR and ER categories rise, IDC projects a ...
Day One Biopharma Expands to ADCs with $55M Drug Acquisition by Lilu Anderson 19.06.2024 "Day One Biopharmaceuticals enhances pipeline, acquiring global rights to promising PTK7-targeting cancer drug DAY301, begins trial soon."